SLT earns a place as first-line therapy

Selective laser trabeculoplasty may supersede drops in glaucoma treatment.

By Samantha Dewundara, MD

Cutting-edge IOLs meet glaucoma

How to approach selecting advanced technology lenses for these challenging patients

By Colin E. Brown, MD, KAROLINNE MAIA ROCHA, MD, PHD

Update on glaucoma diagnostics

Corneal hysteresis, OCT-A and telemedicine are changing the way clinicians diagnose glaucoma.

By Michelle Dalton, ELS

MIGS options to reduce the drop burden

Rethink earlier intervention, ask your patients what they want and reconsider your idea of success.

By Conni Koury, contributing writer

Treating dry eye in glaucoma patients

A review of current management guidelines and supporting literature.

By Shawn Sell, MD, Patrizia Colmenares, OD, Lauren Mason, BS, et al.

Glaucoma treatment takes teamwork

In managing your glaucoma patients, collaborating with optometrists has significant benefits for both of you — as well as your patients.

By Joseph F. Jalkiewicz, contributing writer

Overcome patient communication barriers

Advice on getting your glaucoma patients to open up to you and your clinic staff.

By Oluwatosin Smith, MD

Guest Editorial

Maintaining 20/20 vision despite glaucoma

By Constance O. Okeke, MD, MSCE

Coding & Reimbursement

ECP coding and billing update

By Suzanne L. Corcoran, COE

Quick Hits

By By ReN

ENHANCING PRACTICE PERFORMANCE

Hallmarks of an aligned practice

By Corinne Z. Wohl, MHSA, COE, John B. Pinto

SPOTLIGHT ON TECHNOLOGY & TECHNIQUE

Refined lasers for YAG and SLT

By LOUIS PILLA, CONTRIBUTING EDITOR

INDUSTRY INSIDER

Ivantis' Dave Van Meter

Faculty

Recent iStent inject® Studies Yield Promising Results

20/20 UNHAPPY: WHAT NEXT?

Using an integrated treatment approach that addresses all comorbidities

Early Results of Second-Generation Trabecular Micro-Bypass Stents with Cataract Surgery in a Real-World Setting

Early Single-Surgeon Experience with iStent inject® with Cataract Surgery

IS THIS KERATOCONUS?

Preoperative evaluation uncovers ocular surface disease

Initial Real-World U.S. Experience with iStent inject® in Combination with Cataract Surgery

NEW THERAPIES TO MANAGE MGD

Urgent care in the setting of meibomian gland atrophy

Early Real-World Outcomes with Second-Generation Trabecular Micro-Bypass Stents Implanted in Combination with Cataract Surgery

Early Experience with Second-Generation Trabecular Micro-Bypass Implantation with Cataract Surgery

Early U.S. Experience with iStent inject® with Cataract Surgery

Ophthalmology's response to COVID-19

Updates on the impact on the ophthalmic industry and practices, and the fight to overcome the pandemic.

By OM staff